Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
NCT00155259
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
47
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Docetaxel , Cisplatin , Capecitabine
Sponsor
National Taiwan University Hospital